AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Skorski et al. reported the first direct data on PI3K (both sub-units) involvement in CML cell transformation [51], demonstrating how its downstream effector, AKT, was a critical growth regulatory switch in BCR-ABL1-expressing cells [52].